Blood Pressure Medication Recall: Over 25,000 Bottles Pulled Nationwide Over Dissolution Failure
If you take medication to manage high blood pressure, you may want to check your prescription bottle. An India-based pharmaceutical company has voluntarily recalled more than 25,000 bottles of a common blood pressure drug sold across the United States after the medication failed a critical quality test. Inventia Healthcare Limited, headquartered in Mumbai, issued two recalls for its chlorthalidone tablets because the product did not meet dissolution specifications, according to the Food and Drug Administration (FDA).
The recalls involve 25 mg tablets from batch number RISA24002, with an expiration date of March 2027. One recall covers 13,567 bottles, while the total number of bottles recalled across both actions exceeds 25,000. The problem: the medication does not dissolve or break down at the correct speed in the body. This can affect how the active ingredient is absorbed, potentially reducing the dosage that reaches the bloodstream and compromising the drug’s effectiveness in lowering blood pressure.
Chlorthalidone is a widely prescribed diuretic used to treat hypertension. For patients relying on it to keep their blood pressure under control, a formulation that fails to dissolve properly could mean inadequate treatment. The FDA has classified the recalls, though the specific classification was not immediately detailed. The affected bottles were distributed nationwide, so consumers should carefully examine their medication labels for the batch number and expiration date.
This recall highlights ongoing concerns about the quality of imported generic medications. Patients who have the recalled chlorthalidone should not stop taking their medication without consulting a healthcare professional, as abruptly discontinuing blood pressure treatment can be dangerous. Instead, they should contact their pharmacist or doctor to arrange a replacement or alternative. The FDA encourages anyone with questions to reach out to the agency or the manufacturer for more information.
Shimanta Das 
